{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T08:40:04Z","timestamp":1744879204037,"version":"3.40.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>To investigate the OCT macular changes in type 1 ROP one month following Ranibizumab injections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Preterm infants with type 1 ROP indicated for Ranibizumab injections were included in this study. Handheld OCT imaging was performed at baseline, 1\u00a0week, and 1\u00a0month post injection. Central full thickness (CFT), inner retinal layer (IRL), and outer retinal layer (ORL) thickness measurements were taken from foveal center and parafoveal region.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>24 eyes of 12 infants were included in this study. There were no significant changes in the mean CFT and IRL thickness at 1\u00a0month (p\u2009=\u20090.5 and 0.1 respectively). However, there was significant increase in the mean ORL thickness at 1\u00a0month (69.9\u2009\u00b1\u200916, 96.1\u2009\u00b1\u200925 at baseline and one month respectively, p\u2009&lt;\u20090.001), with differentiation (appearance of IS\/OS junction\u2009\u00b1\u2009ELM) in 55.6% of eyes. Macular edema (ME) was observed in 12 eyes (50%) and was associated with smaller birth weight (p\u2009=\u20090.0290). There was no significant decrease in mean CFT in eyes with ME at 1\u00a0month (p\u2009=\u20090.13), with complete resolution in only 6 eyes (50%) during the study period. Regression of plus was associated with lower CFT (1\u00a0week and 1\u00a0month; p\u2009=\u20090.02 and 0.03, respectively).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Ranibizumab treated eyes in type 1 show ORL thickening and differentiation but with inadequate resolution of ME.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40942-025-00664-7","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T08:05:26Z","timestamp":1744877126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["OCT macular changes in type 1 ROP following Ranibizumab injections"],"prefix":"10.1186","volume":"11","author":[{"given":"Rawan","family":"Hosny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jylan","family":"Gouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer A.","family":"Macky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany","family":"Mekkawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdussalam M.","family":"Abdullatif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"5","key":"664_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","volume":"63","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63(5):618\u201337.","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"664_CR2","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0161-6420(01)00540-1","volume":"108","author":"WV Good","year":"2001","unstructured":"Good WV, Hardy RJ. The multicenter study of early treatment for retinopathy of prematurity (ETROP). Ophthalmology. 2001;108(6):1013\u20134.","journal-title":"Ophthalmology"},{"issue":"7","key":"664_CR3","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ophtha.2011.04.028","volume":"118","author":"DM Moshfeghi","year":"2011","unstructured":"Moshfeghi DM, Berrocal AM. Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice. Ophthalmology. 2011;118(7):1227\u20138.","journal-title":"Ophthalmology"},{"issue":"10208","key":"664_CR4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","volume":"394","author":"A Stahl","year":"2019","unstructured":"Stahl A, Lepore D, Fielder A, et al. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet. 2019;394(10208):1551\u20139.","journal-title":"Lancet"},{"issue":"4","key":"664_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1001\/jama.2022.10564","volume":"328","author":"A Stahl","year":"2022","unstructured":"Stahl A, Sukgen EA, Wu WC, et al. Effect of intravitreal aflibercept vs laser photocoagulation on treatment success of retinopathy of prematurity: the FIREFLEYE randomized clinical trial. JAMA. 2022;328(4):348\u201359. https:\/\/doi.org\/10.1001\/jama.2022.10564.","journal-title":"JAMA"},{"issue":"2","key":"664_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.clp.2013.02.007","volume":"40","author":"RS Maldonado","year":"2013","unstructured":"Maldonado RS, Toth CA. Optical coherence tomography in retinopathy of prematurity: looking beyond the vessels. Clin Perinatol. 2013;40(2):271\u201396. https:\/\/doi.org\/10.1016\/j.clp.2013.02.007.","journal-title":"Clin Perinatol"},{"issue":"12","key":"664_CR7","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1001\/archophthalmol.2012.2118","volume":"130","author":"DK Wallace","year":"2012","unstructured":"Wallace DK, Bremer DL, Good WV, et al. Correlation of recognition visual acuity with posterior retinal structure in advanced retinopathy of prematurity. Arch Ophthalmol. 2012;130(12):1512\u20136. https:\/\/doi.org\/10.1001\/archophthalmol.2012.2118.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"664_CR8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/bjo.2005.068304","volume":"90","author":"E McLoone","year":"2006","unstructured":"McLoone E, O\u2019keefe M, McLoone S, Lanigan B. Long term functional and structural outcomes of laser therapy for retinopathy of prematurity. Br J Ophthalmol. 2006;90(6):754\u20139.","journal-title":"Br J Ophthalmol."},{"issue":"1","key":"664_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/eye.2009.63","volume":"24","author":"CS Yang","year":"2010","unstructured":"Yang CS, Wang AG, Sung CS, Hsu WM, Lee FL, Lee SM. Long-term visual outcomes of laser-treated threshold retinopathy of prematurity: a study of refractive status at 7 years. Eye. 2010;24(1):14\u201320.","journal-title":"Eye"},{"issue":"6","key":"664_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jaapos.2017.06.024","volume":"21","author":"A Clark","year":"2017","unstructured":"Clark A, Wright T, Isaac M, Westall C, Mireskandari K, Tehrani NN. Macular morphology following unilateral bevacizumab injection for retinopathy of prematurity: An OCT study. J Am Assoc Pediatr Ophthalmol Strabismus. 2017;21(6):499\u2013501.","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"issue":"3","key":"664_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3928\/01913913-20150326-12","volume":"52","author":"MK Erol","year":"2015","unstructured":"Erol MK, Coban DT, \u00d6zdemir \u00d6, Tunay Z\u00d6, Bilgin AB, Dogan B. Spectral-Domain OCT analyses of macular changes after ranibizumab therapy for Type 1 retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 2015;52(3):152\u20138.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"3","key":"664_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ophtha.2017.09.020","volume":"125","author":"RN Vogel","year":"2018","unstructured":"Vogel RN, Strampe M, Fagbemi OE, et al. Foveal development in infants treated with bevacizumab or laser photocoagulation for retinopathy of prematurity. Ophthalmology. 2018;125(3):444\u201352.","journal-title":"Ophthalmology"},{"issue":"5","key":"664_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/archopthalmol.2011.1846","volume":"130","author":"RS Maldonado","year":"2012","unstructured":"Maldonado RS, O\u2019Connell R, Ascher SB, et al. Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity. Arch Ophthalmol. 2012;130(5):569\u201378.","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"664_CR14","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.ophtha.2011.05.028","volume":"118","author":"RS Maldonado","year":"2011","unstructured":"Maldonado RS, O\u2019Connell RV, Sarin N, et al. Dynamics of human foveal development after premature birth. Ophthalmology. 2011;118(12):2315\u201325. https:\/\/doi.org\/10.1016\/j.ophtha.2011.05.028.","journal-title":"Ophthalmology"},{"issue":"8","key":"664_CR15","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.ophtha.2013.01.028","volume":"120","author":"AM Dubis","year":"2013","unstructured":"Dubis AM, Subramaniam CD, Godara P, Carroll J, Costakos DM. Subclinical macular findings in infants screened for retinopathy of prematurity with spectral-domain optical coherence tomography. Ophthalmology. 2013;120(8):1665\u201371.","journal-title":"Ophthalmology"},{"issue":"5","key":"664_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/archopthalmol.2011.1846","volume":"130","author":"RS Maldonado","year":"2012","unstructured":"Maldonado RS, O\u2019Connell R, Ascher SB, et al. Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity. Arch Ophthalmol. 2012;130(5):569\u201378. https:\/\/doi.org\/10.1001\/archopthalmol.2011.1846.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"664_CR17","first-page":"614","volume":"26","author":"RM Robb","year":"1985","unstructured":"Robb RM. Regional changes in retinal pigment epithelial cell density during ocular development. Invest Ophthalmol Vis Sci. 1985;26(5):614\u201320.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"664_CR18","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archopht.1995.01100080071031","volume":"113","author":"MR Hee","year":"1995","unstructured":"Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995;113(8):1019\u201329.","journal-title":"Arch Ophthalmol"},{"key":"664_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0039-6257(84)90233-9","volume":"28","author":"M Yanoff","year":"1984","unstructured":"Yanoff M, Fine BS, Brucker AJ, Eagle RC Jr. Pathology of human cystoid macular edema. Surv Ophthalmol. 1984;28:505\u201311.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"664_CR20","first-page":"468653","volume":"2014","author":"MK Erol","year":"2014","unstructured":"Erol MK, Ozdemir O, Turgut Coban D, et al. Macular findings obtained by spectral domain optical coherence tomography in retinopathy of prematurity. J Ophthalmol. 2014;2014(1):468653.","journal-title":"J Ophthalmol."},{"issue":"8","key":"664_CR21","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1167\/iovs.10-7155","volume":"52","author":"A Vinekar","year":"2011","unstructured":"Vinekar A, Avadhani K, Sivakumar M, et al. Understanding clinically undetected macular changes in early retinopathy of prematurity on spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52(8):5183\u20138. https:\/\/doi.org\/10.1167\/iovs.10-7155.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"664_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ajo.2011.06.017","volume":"153","author":"MT Cabrera","year":"2012","unstructured":"Cabrera MT, Maldonado RS, Toth CA, et al. Subfoveal fluid in healthy full-term newborns observed by handheld spectral-domain optical coherence tomography. Am J Ophthalmol. 2012;153(1):167\u201375.","journal-title":"Am J Ophthalmol."}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00664-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T08:05:27Z","timestamp":1744877127000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00664-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00664-7","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants. This study followed the tenets of Declaration of Helsinki and the study protocol was revised and approved by ethical committee at Kasr Al Ainy hospital Cairo University with Institutional review board (IRB) number MS-23-2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"47"}}